[Influenza vaccination in dialysis patients].
50 stabilized long-term hemodialysis patients were randomly selected to receive one intramuscular injection of a new influenza subunit vaccine containing only the surface antigens hemagglutinin and neuraminidase, or of an adjuvant containing whole virus vaccine. Both vaccines contained strains A/Victoria/3/75 and B/Hongkong/8/73. Both vaccines were very well tolerated and caused significant rises in the antibody titers within 4 weeks against both strains. The subunit vaccine produced significantly higher antibody titers against strain A than the whole virus vaccine.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D005260:Female; D006388:Hemagglutinins / Q000032:analysis; D006801:Humans; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000032:analysis / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009439:Neuraminidase / Q000032:analysis; D006435:Renal Dialysis
D000914:Antibodies, Viral; D006388:Hemagglutinins; D007252:Influenza Vaccines; D009439:Neuraminidase
Grippeimpfung bei Dialysepatienten.